Cost Mitigation Techniques for Medication Management

This document is a technical report detailing various cost mitigation techniques applied to medication management within medical service agreements (MSAs). It outlines several strategies that resulted in significant savings across multiple cases. For instance, a switch from Meloxicam 5MG to a lower dosage of 7.5MG led to a savings of $622,000. Additionally, a successful rebuttal to the Centers for Medicare and Medicaid Services (CMS) resulted in a reduction of over $145,000 in catheter supply costs. The report describes how a price drop for Omeprazole allowed for a revision in a prior MSA, yielding savings of $105,000. Other successful strategies included the removal of Ondansetron from an MSA, which resulted in a savings of $1.8 million, and an amended review that saved over $1.025 million by discontinuing certain medications. The document emphasizes the importance of proactive cost mitigation outreach and collaboration with healthcare providers.